Product NDC: | 0173-0824 |
Proprietary Name: | RYTHMOL |
Non Proprietary Name: | propafenone hydrochloride |
Active Ingredient(s): | 325 mg/1 & nbsp; propafenone hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0173-0824 |
Labeler Name: | GlaxoSmithKline LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021416 |
Marketing Category: | NDA |
Start Marketing Date: | 20110317 |
Package NDC: | 0173-0824-18 |
Package Description: | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0173-0824-18) |
NDC Code | 0173-0824-18 |
Proprietary Name | RYTHMOL |
Package Description | 60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0173-0824-18) |
Product NDC | 0173-0824 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | propafenone hydrochloride |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20110317 |
Marketing Category Name | NDA |
Labeler Name | GlaxoSmithKline LLC |
Substance Name | PROPAFENONE HYDROCHLORIDE |
Strength Number | 325 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Antiarrhythmic [EPC] |